Related Experiment Video
Updated: Aug 22, 2026

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
Published on: January 7, 2018
Should oral glucose tolerance test be a routine examination after a myocardial infarction?
Loghman Henareh1, Margareta Berglund, Stefan Agewall
1Department of Cardiology, Huddinge University Hospital, Karolinska Institute, S-141 86 Stockholm, Sweden.
Insights
A high prevalence of diabetes mellitus (DM) and impaired glucose tolerance (IGT) was found in heart attack survivors without prior DM diagnosis. Routine oral glucose tolerance testing is recommended post-myocardial infarction.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Disorders
Background:
- Diabetes mellitus (DM) and impaired glucose tolerance (IGT) are established cardiovascular risk factors.
- Patients recovering from myocardial infarction (MI) often have undiagnosed glucose metabolism abnormalities.
Purpose of the Study:
- To determine the prevalence of DM and IGT in patients discharged from cardiac care units (CCU) after MI, who had no prior DM diagnosis.
Main Methods:
- 110 patients (31-80 years) with MI 1-12 months prior underwent an oral glucose tolerance test (OGTT).
- Patients with pre-existing DM were excluded from the study.
- A standard 75g oral glucose challenge was administered.
Main Results:
- The study identified IGT in 26% (29/110) and DM in 12% (13/110) of patients via OGTT.
- Fasting plasma glucose (FPG) alone detected only 19% of patients with abnormal glucose tolerance.
- Overall, 38% of patients without known DM had pathological glucose tolerance post-MI.
Conclusions:
- Pathological glucose tolerance is a significant cardiovascular risk factor following myocardial infarction.
- Oral glucose tolerance testing (OGTT) should be considered a routine screening tool for patients post-MI without a known DM diagnosis.
Background:
Diabetes mellitus (DM) and impaired glucose tolerance (IGT) are important cardiovascular risk factors. The objective of this study was to assess the prevalence of DM and IGT in patients discharged from the CCU without known DM after a myocardial infarction.
Methods:
One hundred and ten patients, men and women aged 31-80 years with a myocardial infarction 1-12 months before inclusion were examined with oral glucose tolerance test. Patients with known DM were excluded. A standard oral glucose test (OGTT) with 75 g of glucose was performed.
Results:
IGT was observed in 29 (26%) patients and DM in 13 (12%) patients in the OGTT. If only fasting plasma glucose (FPG) was used alone five (38.5%) patients with diabetes subjects and three (10.3%) with IGT were identified. Thus, a FPG test alone identified only 19.0% of the patients with pathological OGTT. The prevalence of DM and IGT in patients discharged from the CCU after a myocardial infarction without known DM diagnosis was high (38%). A fasting glucose alone failed to identify more than 80% of the patients with pathological glucose tolerance in this study.
Conclusion:
Since pathological glucose tolerance is an important cardiovascular risk factor, oral glucose tolerance test should be considered as a routine test after a myocardial infarction in subjects without known DM.
Related Concept Videos
Exercise Stress Test
Exercise stress testing, commonly known as a treadmill test, is a noninvasive procedure used to evaluate cardiovascular function and diagnose heart conditions.
Definition
An exercise stress test measures the heart's response to exertion using a treadmill or stationary bicycle. Chest electrodes record the heart's electrical activity through an ECG, and blood pressure is monitored regularly.
Purposes
Hyperglycemia
Imaging Studies for Cardiovascular System I:Echocardiography
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion, evaluates...
Imaging Studies for Cardiovascular System V: CT
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Coronary Artery Disease V: Interprofessional Care
